AI Verdict
AMGN has stronger fundamentals based on our AI analysis.
AMGN vs GILD Fundamental Comparison
| Metric | AMGN | GILD |
|---|---|---|
| Revenue | $36.8B | $29.4B |
| Net Income | $7.7B | $8.5B |
| Net Margin | 21.0% | 28.9% |
| ROE | 89.1% | 37.5% |
| ROA | 8.5% | 14.4% |
| Current Ratio | 1.14x | 1.55x |
| Debt/Equity | 6.31x | 1.10x |
| EPS | $14.23 | $6.78 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
AMGN vs GILD: Frequently Asked Questions
Is AMGN or GILD a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMGN has stronger fundamentals. AMGN is rated BUY (84% confidence) while GILD is rated BUY (82% confidence). This is not investment advice.
How does AMGN compare to GILD fundamentally?
AMGEN INC has ROE of 89.1% vs GILEAD SCIENCES, INC.'s 37.5%. Net margins are 21.0% vs 28.9% respectively.
Which stock pays higher dividends, AMGN or GILD?
AMGN has a dividend yield of N/A or no dividend while GILD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in AMGN or GILD for long term?
For long-term investing, consider that AMGN has BUY rating with 84% confidence, while GILD has BUY rating with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about AMGN vs GILD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For AMGN vs GILD, the AI consensus favors AMGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.